Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Signal Medical Corporation
EIR
•Signal Medical Corporation•February 3, 2017

Signal Medical Corporation – FDA EIR, Feb 3, 2017

Record Details

Signal Medical Corporation underwent an FDA inspection from January 23 to February 3, 2017, focusing on its medical device manufacturing operations in Marysville, MI. This compliance follow-up inspection was conducted under the Quality System Regulation (QSR) and relevant FDA guidance. The inspection identified significant issues, some of which were recurring from previous assessments.

The FDA issued a seven-item Form FDA 483, detailing key violations. These included the repeated failure to adequately validate the packaging design for sterile hip implant components and inadequacies in their Corrective and Preventive Action (CAPA) procedures. Specifically, the company had not identified the root cause for persistent rust-colored staining on porous-coated implants and failed to implement preventive actions despite trends in nonconforming products. A critical manufacturing process, specifically the (b)(4) process for removing impurities from implants, was found to be inadequately validated. Additionally, the company failed to properly review, evaluate, and investigate complaints, create records for all known complaints, and establish agreements with suppliers. A significant finding, previously discussed, was the failure to report a correction or removal of a device to the FDA.

Signal Medical Corporation's management acknowledged these observations and committed to correcting the issues, promising to submit a plan for corrective action to the Detroit District Office within fifteen business days.

Company
Signal Medical Corporation
Inspection date
February 3, 2017
Product type
devices
Office
Detroit District Office
Person
  • Amy Graf
View Company Profile

ID · 957472d2-eb97-440f-b850-a600d4d3ee21

Violation Codes10
21 CFR 820.30(g)21 CFR 820.100(a)21 CFR 820.75(a)21 CFR 820.198(c)21 CFR 820.198(a)21 CFR 820.50(b)21 CFR 806.10(a)(1)21 CFR 806.2(i)21 CFR 801.121 CFR 820

Full citation text and observation details available on the Dashboard.

Other documents for Signal Medical Corporation
  • 483 - 2023-04-10April 10, 2023
  • WARNING_LETTER - 2014-08-11August 11, 2014

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Signal Medical Corporation
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.